Circulating Interleukin-6 Levels and Incident Ischemic Stroke
A Systematic Review and Meta-analysis of Prospective Studies
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 3, 2021
- Accepted in final form December 21, 2021
- First Published December 30, 2021.
Article Versions
- Previous version (December 30, 2021 - 12:45).
- You are viewing the most recent version of this article.
Author Disclosures
- Andreas Papadopoulos, MD,
- Konstantinos Palaiopanos, MD,
- Harry Björkbacka, PhD,
- Annette Peters, PhD,
- James A. de Lemos, MD,
- Sudha Seshadri, MD,
- Martin Dichgans, MD and
- Marios K. Georgakis, MD, PhD
- Andreas Papadopoulos, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Konstantinos Palaiopanos, MD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Harry Björkbacka, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Annette Peters, PhD,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- James A. de Lemos, MD,
DSMB for Novo Nordisc, Eli Lilly, Astra Zeneca, Regeneron, Steering committee for Amgen, all unrelated to study
NONE
NONE
Executive Editor Circulation
Patent for use of troponin for heart failure prediction, unrelated to study
NONE
NONE
Consultant for Sieman's Health Care Diagnostics, Ortho Clinical Diagnostics, unrelated to study question
NONE
NONE
NONE
Grants from Roche Diagnostics and Abbott Diagnostics, unrelated to study questions.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sudha Seshadri, MD,
Steering Committee of the Cardiovascular Health Study; Senate of German Center for Neurodegenerative Diseases (DZNE)
NONE
NONE
Editorial Board of Stroke and Alzheimer's and Dementia
NONE
NONE
NONE
Consulted for Biogen
NONE
NONE
NONE
NONE
NIA AG033040, AG049607,AG058464, AG059421, AG063507 AG054076, AG052409, AG058589, AG066524 NINDS NS017950, NS100605
NONE
Alzheimer Association grant
NONE
NONE
NONE
NONE
NONE
NONE
- Martin Dichgans, MD and
NONE
NONE
(1)Bayer Vital, funding for travel to speak (2)Pfizer Pharma GmbH, funding for travel to speak (3)Bristol MYERS SQUIBB, funding for travel to speak
(1)Stroke (AHA), Section Editor, 2015 - present (2)International Journal of Stroke (WSO), Section Editor, 2013 - present (3)Frontiers in Stroke, Associate Editor, 2010 - present (4) Annals of Neurology, Editorial Board Member, 2017 - present (5) European Stroke Journal (ESO), Editor, 2016 - present (6) Nervenarzt, Section Editor, 2013 - present
NONE
NONE
NONE
Ever Neuro Pharma
NONE
NONE
NONE
NONE
(1) European Union (EU-Horizon 2020, GA No. 667375), principal investigator,12/2015-11/2020 (2) European Union (EU-Horizon 2020, GA No. 666881), Coordinator, 01/2016-12/2020 (3) DFG, EXC 1010/1, principal investigator, 01/2013- 06/2022 (4) DFG, SFB 1123/1, B03, principal investigator, 10/2014- 07/2022 (5) DFG, GZ: DI 722/13-1, principal investigator, 01/2017- 07/2021 (6) Fondation Leducq, Grant no.12 CVD 01, principal investigator, 10/2012-09/2018 (7) National Institutes of Health, principal investigator, 01/2018 - 12/2022 (8) Bayern Innovativ Gesellschaft für Innovation und Wissenstransfer mbH, principal investigator, 12/2018 - 11/2023 (9) DFG, GZ: DI 722/16-1, principal investigator, 07/2019 - 07/2022
NONE
(1) Vascular Dementia Research Foundation
NONE
NONE
NONE
NONE
NONE
NONE
- Marios K. Georgakis, MD, PhD
NONE
NONE
NONE
Frontiers in Neurology (since June 2021 - Associate Editor in Stroke section)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
German Research Foundation (DFG, GZ: GE 3461/1-1) LMU Munich (FöFoLe program Reg.-Nr. 1120)
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Radiology (A.P.), 401 General Military Hospital of Athens; National Public Health Organization (K.P.), Athens, Greece; Department of Clinical Sciences Malmö (H.B.), Lund University, Sweden; Institute of Epidemiology (A.P.), Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg; German Center for Diabetes Research (DZD) (A.P.), München-Neuherberg, Neuherberg; German Research Center for Cardiovascular Disease (DZHK) (A.P.), Partner Site Munich Heart Alliance; Institute of Medical Information Sciences, Biometry and Epidemiology (A.P.), and Institute for Stroke and Dementia Research, University Hospital (M.D., M.K.G.), Ludwig-Maximilians-University, Munich, Germany; Division of Cardiology (J.A.d.L.), University of Texas Southwestern Medical Center, Dallas; National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study (S.S.), Framingham; Department of Medicine (S.S.), Boston University School of Medicine, MA; Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases (S.S.), University of Texas Health Sciences Center, San Antonio; Munich Cluster for Systems Neurology (SyNergy) (M.D.); and German Centre for Neurodegenerative Diseases (DZNE) (M.D.), Munich, Germany. M.K.G. is currently at the Center for Genomic Medicine, Massachusetts General Hospital, Boston and the Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA.
- Correspondence
Dr. Georgakis marios.georgakis{at}med.uni-muenchen.de
Article usage
Disputes & Debates: Rapid online correspondence
- Author Response: Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies
- Andreas Papadopoulos, Radiology Resident, M.D., Department of Radiology, 401 General Military Hospital of Athens, Greece
- Marios K. Georgakis, Postdoctoral Research Fellow, Harvard Medical School - Massachusetts General Hospital
Submitted January 25, 2022 - Reader Response: Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies
- Vinod K Gupta, Physician-Medical Director, GUPTA MEDICAL CENTRE, MIGRAINE-HEADACHE INSTITUTE, S-407, Greater Kailash-Part Two, New Delhi, INDIA-110048
Submitted January 04, 2022
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.